E-ISSN 2146-9369 | ISSN 2146-3158
 

Case Report 


Drug interaction of bocepravir and amlodipine in a patient with hepatitis C: A Cardiovascular follow-up

Çiğdem Kader, Hüseyin Ede, Ayşe Erbay, Alirıza Erbay.


Cited By:4

Abstract
ABSTRACT
Boceprevir is a NS3/4A hepatitis C virus (HCV) protease inhibitor, used in combination with peginterferon and ribavirin to treat HCV. Boceprevir undergoes extensive metabolism via cytochrome P450-mediated oxidation and ketoreduction by cytosolic aldo-keto reductases. Amlodipine has been used for the treatment of patients with hypertension and also metabolised through cytochrome P450 pathway. Here, we presented a case of boceprevir and amlodipine interaction in a patient with chronic HCV and her echocardiography and electrocardiographic follow-up results. J Microbiol Infect Dis 2015;5(1): 32-35

Key words: Amlodipine, boceprevir, drug ınteraction


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Çiğdem Kader
Articles by Hüseyin Ede
Articles by Ayşe Erbay
Articles by Alirıza Erbay
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Ciğdem Kader, Huseyin Ede, Ayşe Erbay, Alirıza Erbay. Drug interaction of bocepravir and amlodipine in a patient with hepatitis C: A Cardiovascular follow-up. J Microbiol Infect Dis. 2015; 5(1): 32-35 . doi:10.5799/jmid2015.01.0172


Web Style

Ciğdem Kader, Huseyin Ede, Ayşe Erbay, Alirıza Erbay. Drug interaction of bocepravir and amlodipine in a patient with hepatitis C: A Cardiovascular follow-up. https://www.jmidonline.org/?mno=302657252 [Access: November 23, 2024]. doi:10.5799/jmid2015.01.0172


AMA (American Medical Association) Style

Ciğdem Kader, Huseyin Ede, Ayşe Erbay, Alirıza Erbay. Drug interaction of bocepravir and amlodipine in a patient with hepatitis C: A Cardiovascular follow-up. J Microbiol Infect Dis. 2015; 5(1): 32-35 . doi:10.5799/jmid2015.01.0172



Vancouver/ICMJE Style

Ciğdem Kader, Huseyin Ede, Ayşe Erbay, Alirıza Erbay. Drug interaction of bocepravir and amlodipine in a patient with hepatitis C: A Cardiovascular follow-up. J Microbiol Infect Dis. (2015), [cited November 23, 2024]; 5(1): 32-35 . doi:10.5799/jmid2015.01.0172



Harvard Style

Ciğdem Kader, Huseyin Ede, Ayşe Erbay, Alirıza Erbay (2015) Drug interaction of bocepravir and amlodipine in a patient with hepatitis C: A Cardiovascular follow-up. J Microbiol Infect Dis, 5 (1), 32-35 . doi:10.5799/jmid2015.01.0172



Turabian Style

Ciğdem Kader, Huseyin Ede, Ayşe Erbay, Alirıza Erbay. 2015. Drug interaction of bocepravir and amlodipine in a patient with hepatitis C: A Cardiovascular follow-up. Journal of Microbiology and Infectious Diseases, 5 (1), 32-35 . doi:10.5799/jmid2015.01.0172



Chicago Style

Ciğdem Kader, Huseyin Ede, Ayşe Erbay, Alirıza Erbay. "Drug interaction of bocepravir and amlodipine in a patient with hepatitis C: A Cardiovascular follow-up." Journal of Microbiology and Infectious Diseases 5 (2015), 32-35 . doi:10.5799/jmid2015.01.0172



MLA (The Modern Language Association) Style

Ciğdem Kader, Huseyin Ede, Ayşe Erbay, Alirıza Erbay. "Drug interaction of bocepravir and amlodipine in a patient with hepatitis C: A Cardiovascular follow-up." Journal of Microbiology and Infectious Diseases 5.1 (2015), 32-35 . Print. doi:10.5799/jmid2015.01.0172



APA (American Psychological Association) Style

Ciğdem Kader, Huseyin Ede, Ayşe Erbay, Alirıza Erbay (2015) Drug interaction of bocepravir and amlodipine in a patient with hepatitis C: A Cardiovascular follow-up. Journal of Microbiology and Infectious Diseases, 5 (1), 32-35 . doi:10.5799/jmid2015.01.0172